| TOUŠEK, Petr, Viktor KOČKA, Martin MALÝ, Martin KOZEL, Petr ROBERT, Martin HAJŠL, Jiří JARKOVSKÝ a Petr WIDIMSKÝ. Two-year follow-up after bioresorbable vascular scaffold implantation in STEMI patients - Results from PRAGUE-19 study. International Journal of Cardiology. Clare: Elsevier Ireland Ltd., 2016, roč. 209, "neuvedeno", s. 20-21. ISSN 0167-5273. Dostupné z: https://dx.doi.org/10.1016/j.ijcard.2016.02.029. |
Další formáty:
BibTeX
LaTeX
RIS
@article{1349621,
author = {Toušek, Petr and Kočka, Viktor and Malý, Martin and Kozel, Martin and Robert, Petr and Hajšl, Martin and Jarkovský, Jiří and Widimský, Petr},
article_location = {Clare},
article_number = {"neuvedeno"},
doi = {http://dx.doi.org/10.1016/j.ijcard.2016.02.029},
keywords = {Bioresorbable vascular scaffold; STEMI; Long-term follow-up; Dual antiplatelet treatment termination},
language = {eng},
issn = {0167-5273},
journal = {International Journal of Cardiology},
title = {Two-year follow-up after bioresorbable vascular scaffold implantation in STEMI patients - Results from PRAGUE-19 study},
volume = {209},
year = {2016}
}
TY - JOUR
ID - 1349621
AU - Toušek, Petr - Kočka, Viktor - Malý, Martin - Kozel, Martin - Robert, Petr - Hajšl, Martin - Jarkovský, Jiří - Widimský, Petr
PY - 2016
TI - Two-year follow-up after bioresorbable vascular scaffold implantation in STEMI patients - Results from PRAGUE-19 study
JF - International Journal of Cardiology
VL - 209
IS - "neuvedeno"
SP - 20-21
EP - 20-21
PB - Elsevier Ireland Ltd.
SN - 01675273
KW - Bioresorbable vascular scaffold
KW - STEMI
KW - Long-term follow-up
KW - Dual antiplatelet treatment termination
N2 - Several studies have shown early andmid-termsafety and feasibility of everolimus-eluting bioresorbable vascular scaffold (BVS) implantation in different clinical settings including patients with ST-elevationmyocardial infarction (STEMI). Favourable long-term clinical results have been shown in stable patients. Recently, one year clinical follow-up has been presented in STEMI patients with very encouraging results. On the other hand, the rate of early and mid-term stent thrombosis during dual antiplatelet treatment (DAPT) in this clinical setting is not negligible. Clinical outcome of STEMI patientswith implanted BVS after DAPT termination is not known. Thus, we sought to evaluate a 2 year clinical follow-up of patients included in the pilot phase of PRAGUE-19 study with published short-term clinical results.
ER -
TOUŠEK, Petr, Viktor KOČKA, Martin MALÝ, Martin KOZEL, Petr ROBERT, Martin HAJŠL, Jiří JARKOVSKÝ a Petr WIDIMSKÝ. Two-year follow-up after bioresorbable vascular scaffold implantation in STEMI patients - Results from PRAGUE-19 study. \textit{International Journal of Cardiology}. Clare: Elsevier Ireland Ltd., 2016, roč.~209, ''neuvedeno'', s.~20-21. ISSN~0167-5273. Dostupné z: https://dx.doi.org/10.1016/j.ijcard.2016.02.029.
|
